BioRestorative Therapies BRTX
NASDAQ BRTX
$2.20 -0.07 (-3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioRestorative Therapies (BRTX) Change in Accured Expenses (2010 - 2025)

Updated

BioRestorative Therapies (BRTX) recorded Change in Accured Expenses of $332,296 in Q4 2025, up 433.8% from $62,248 a year earlier and up 162.6% from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Change in Accured Expenses (2010 - 2025) Analysis & Trends

For FY2025, BioRestorative Therapies reported Change in Accured Expenses of $195,281, up 495.4% from FY2024.

  • Annual Change in Accured Expenses has a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
  • Across earlier years, Change in Accured Expenses came in at $32,799 in FY2024 (-94.4%), $581,616 in FY2023, -$4,898 in FY2022 and $812,673 in FY2021 (+49.7%).
  • The Q4 2025 figure is the highest quarterly Change in Accured Expenses since Q2 2020.
  • On a year-over-year basis, Change in Accured Expenses rose in three of the last six quarters, with growth averaging 67.9%.
  • Peak year-over-year performance for Change in Accured Expenses in the last five years was growth of 955.1% in Q4 2023, against a decline of 94.6% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $126,545 (Q3 2025), $203,315 (Q2 2025) and -$466,875 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BioRestorative Therapies 976,386.42 -22.96 Mn 17,964.00 332,296.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 332,296.00
Sep 30, 2025 126,545.00
Jun 30, 2025 203,315.00
Mar 31, 2025 -466,875.00
Dec 31, 2024 62,248.00
Sep 30, 2024 234,615.00
Jun 30, 2024 138,525.00
Mar 31, 2024 -402,589.00
Dec 31, 2023 162,734.00
Sep 30, 2023 162,629.00
Jun 30, 2023 153,340.00
Mar 31, 2023 102,913.00
Dec 31, 2022 15,423.00
Sep 30, 2022 -10.00
Jun 30, 2022 -41,378.00
Mar 31, 2022 21,067.00
Dec 31, 2021 284,658.00
Sep 30, 2021 199,841.00
Jun 30, 2021 167,273.00
Mar 31, 2021 160,901.00
API Access

BioRestorative Therapies Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BRTX&period=max&api_key=YOUR_API_KEY